Form 4: Camp4 Therapeutics Director Andrew J. Schwab Granted 9,000 Stock Options

Andrew J. Schwab, a Director and 10% owner of Camp4 Therapeutics Corp, was granted 9,000 stock options with an exercise price of $1.56 per share, vesting on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders.

Summary

• Andrew J. Schwab, a Director and 10% owner of Camp4 Therapeutics Corp (CAMP), was granted 9,000 stock options.
• The options have an exercise price of $1.56 per share.
• The grant date for these options was June 25, 2025.
• The options expire on June 24, 2035.
• The shares underlying the option vest in their entirety on the earlier of the first anniversary of the grant date (June 25, 2026) or the date of the issuer's next annual meeting of stockholders.
• Vesting is contingent upon Mr. Schwab's continued service to the issuer's board of directors through the applicable vesting date.
• Following this transaction, Mr. Schwab beneficially owns 9,000 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an equity grant to a director, which is a neutral event in terms of company performance or outlook. It reflects standard compensation practices.

Positives

• The granting of stock options to a director aligns their interests with shareholders, incentivizing long-term performance and value creation.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The grant of stock options to Andrew J. Schwab, who is both a Director and a 10% owner of Camp4 Therapeutics Corp, constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: The grant of options aligns the director's interests with shareholders, potentially encouraging long-term value creation. It also represents a form of potential dilution if exercised, which is standard for equity compensation.

Next Steps

• The shares underlying the option will vest on the earlier of June 25, 2026, or the date of the issuer's next annual meeting of stockholders, subject to continued service to the board.

Key Dates

Keywords

Camp4 Therapeutics, CAMP, Andrew J. Schwab, SEC Form 4, Stock Options, Beneficial Ownership, Director Compensation, Equity Grant, Insider Transaction